Keywords
Tics
Medication
Social Behavior
Life Quality
How to Cite
Abstract
The aim was to review the historical, and clinical aspects, symptoms, diagnosis, and treatment of Tourette Syndrome (TS) in the literature. The study is a bibliographic review, written in an integrative and systematic manner. (TS) was described from the observation of people who had tics and obscene behavior, in which the sufferer was unable to control them. The “International Statistical Classification of Diseases and Related Health Problems” allocates TS to the group of disorders with emotional disturbances. TS is a chronic neuropsychiatric condition characterized by stereotyped actions, multiple motor tics, and/or vocal tics, which generally appear during early adolescence without specific etiology. The treatment of TS is carried out through a pharmacological and non-pharmacological combination and, in some cases where the treatment is ineffective, surgical treatment. The results demonstrated that pharmacological treatment is effective, but for more satisfactory results it is necessary to associate it with non-pharmacological treatment.
References
Greydanus DE, Tullio J. Tourette’s disorder in children and adolescents. Translational Pediatrics. 2020;9(Suppl 1):S94-S103. doi: 10.21037/tp.2019.09.11
Organização Mundial da Saúde (OMS). CID-10 Classificação Estatística Internacional de Doenças e Problemas Relacionados à Saúde. 10 ed. São Paulo: Universidade de São Paulo; 1997.
Ferreira ACGR. Revisão da Literatura sobre a Síndrome de Tourette. Fed. Nac. das Apaes (Fenapaes) [Internet]. 2019 [acesso em 11 nov 2023];12(2):22-34. Disponível em: https://apaeciencia.org.br/index.php/revista/article/view/126
Robertson MM. Tourette syndrome, associated conditions and the complexities of treatment. BRAIN. 2000;123(3):425-462, 2000. DOI: 10.1093/brain/123.3.425
Mattos JP, Rosso ALZ. Tiques e síndrome de Gilles de la Tourette. Arq. Neuro-Psiquiatr. 1995;53(1):141-146. https://doi.org/10.1590/S0004-282X1995000100022
American Psychiatric Association. Manual diagnóstico e estatístico de transtornos mentais: DSM-5. 5. ed. Porto Alegre: Artmed; 2014.
Deng H, Gao K, Jankovic J. The genetics of Tourette syndrome. Nature Reviews Neurology. 2012;8(4):203-213. DOI: 10.1038/nrneurol.2012.26
Draper A, Stephenson MC, Jackson GM, Pépés S, Morgan PS, Morris PG, Jackson SR. Increased GABA contributes to enhanced control over motor excitability in tourette syndrome. Current Biology. 2014;24(19):2343–2347. DOI: 10.1016/j.cub.2014.08.038
Gonçalves DM, Silva NG, Estevam ID. Síndrome de Tourette e terapia cognitivo-comportamental: um estudo de caso. Rev. bras.ter. cogn. [online]. 2019;15(1):51-58. DOI: 10.5935/1808-5687.20190008
Jimenez-Shahed J. Medical and Surgical Treatments of Tourette Syndrome. Neurol Clin. 2020;38:240-366. DOI: 10.1016/j.ncl.2020.01.006
Weisman H, Qureshi IA, Leckman JF, Scahill L, Bloch MH. Systematic review: pharmacological treatment of tic disorders–efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neurosci Biobehav. 2013;37(6):162-1171. DOI: 10.1016/j.neubiorev.2012.09.008
Jankovic J. Treatment of tics associated with Tourette syndrome. Journal of Neural Transmission. 2000;127(5):843-850. DOI: 10.1007/s00702-019-02105-w
Cheng T, Wallace DM, Ponteri B, Tuli M. Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects. Neuropsychiatric disease and treatment. 2018;14:1351-1361. DOI: 10.2147/NDT.S164307
Marras C, Andrews D, Sime E, Lang AE. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology. 2001;56(5):605-610. DOI: 10.1212/wnl.56.5.605
Müller-Vahl KR. Treatment of Tourette syndrome with cannabinoids. Behavioural neurology. 2013;27(1):119-124, 2013. DOI: 10.3233/BEN-120276
Sokratous S, Kaikoush K, Mpouzika MD, Alexandrou G, Karanikola NM. Attitudes, beliefs and knowledge about medical cannabis among nurses and midwives in Cyprus: a cross-sectional descriptive correlational study. BMC Nurs. 2022;21(1):120. DOI: 10.1186/s12912-022-00887-1
Temel Y, Visser‐Vandewalle V. Surgery in Tourette syndrome. Movement disorders: Official Journal of the Movement Disorder Society. 2004;19(1):3-14. DOI: 10.1002/mds.10649
Jimenez-Shahed J. Design challenges for stimulation trials of Tourette´s syndrome. The Lancet. Neurology. 2015;14(6):563-565. DOI: 10.1016/S1474-4422(15)00043-5
Wang N, Qin DD, Xie YH, Wu XC, Wang DY, Yang H, Li XX, Xiong L, Liang JH. Traditional chinese medicine strategy for patients with tourette syndrome based on clinical efficacy and safety: a meta-analysis of 47 randomized controlled trials. Biomed Res Int. 2021;6630598. DOI: 10.1155/2021/6630598
Wang Y, Zhao L, Li A. Gastrodin-A potential drug used for the treatment of Tourette Syndrome. Journal of Pharmacological Sciences. 2021;145(3):289-295. DOI: 10.1016/j.jphs.2021.01.005
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Global Academic Nursing Journal